Select a Sector or Industry
Drugs - Generic Stock Rankings
-
Accounts Payable
-
Accounts Receivable
-
Accruals
Pro
-
Altman Z-Score
Pro
-
Asset Utilization
-
Beneish M-Score
Pro
-
Book Value
-
Book Value per Share
-
Capital Expenditures
-
Cash Conversion Cycle
Pro
-
Cash Div. Payout Ratio TTM
Pro
-
Cash Financing
-
Cash Financing TTM
-
Cash Investing
-
Cash Investing TTM
-
Cash Operations
-
Cash Operations TTM
-
Cash and Equivalents
-
Cash and ST Investments
-
Current Ratio
-
Days Inventory Outstanding
Pro
-
Days Payable Outstanding
Pro
-
Days Sales Outstanding
Pro
-
Debt to Equity Ratio
-
Dividend Yield
-
EBITDA Margin TTM
Pro
-
EBITDA TTM
Pro
-
EV / EBIT
Pro
-
EV / EBITDA
Pro
-
EV / Free Cash Flow
Pro
-
EV / Revenues
Pro
-
Earnings Per Share
-
Earnings Per Share Growth
-
Earnings Per Share TTM
-
Earnings Yield
-
Effective Tax Rate TTM
Pro
-
Enterprise Value
-
Expenses
-
Expenses TTM
-
Free Cash Flow
-
Free Cash Flow TTM
-
Free Cash Flow Yield
Pro
-
Fundamental Score
Pro
-
Gross Profit Margin
-
Gross Profit TTM
-
Income from Cont. Ops
Pro
-
Interest Expense
-
Interest Income
-
Inventories
-
KZ Index
Pro
-
Liabilities
-
Long Term Debt
-
Market Cap
-
Net Income
-
Net Income TTM
-
Net PP&E
-
Operating Earnings Yield
Pro
-
Operating Margin TTM
Pro
-
Operating PE Ratio
Pro
-
Other Comprehensive Income
Pro
-
PE 10
Pro
-
PE Ratio
-
PE Value
Pro
-
PEG Ratio
-
PS Value
Pro
-
Payout Ratio TTM
Pro
-
Price
-
Price / Book Value
-
Price / Sales Ratio
-
Price / Tangible Book Value
Pro
-
Profit Margin
-
R&D Expense
-
Receivables Turnover
-
Retained Earnings
-
Retained Earnings Growth
-
Return on Assets
-
Return on Equity
-
Return on Invested Capital
Pro
-
Revenue Growth
-
Revenue Per Share TTM
-
Revenues
-
Revenues TTM
-
SG&A Expense
-
Shareholders Equity
-
Shares Outstanding
-
Stock Buybacks
-
Tangible Book Value
Pro
-
Tangible Book Value Per Share
Pro
-
Tangible Common Equity Ratio
Pro
-
Times Interest Earned TTM
Pro
-
Total Assets
-
Valuation (Historical Mult.)
Pro
-
Valuation Percentage
Pro
-
Value Score
Pro
Select from over 70 financial rankings
Or choose from these popular rankings:
Market Cap
View All
1
MYL
Mylan
8.957B
2
WPI
Watson Pharmaceuticals
8.870B
3
SLXP
Salix Pharmaceuticals
3.056B
4
MRX
Medicis Pharmaceutical Corporati...
2.070B
5
PRX
Par Pharmaceutical Companies
1.272B
PE Ratio
View All
1
HITK
Hi - Tech Pharmacal
7.234
2
MYL
Mylan
16.26
3
MRX
Medicis Pharmaceutical Corporati...
21.04
4
PRX
Par Pharmaceutical Companies
22.44
5
AKRX
Akorn
30.93
Dividend Yield
View All
1
MRX
Medicis Pharmaceutical Corporati...
1.10%
2
TBET
Tibet Pharmaceuticals
0.00%
2
SLXP
Salix Pharmaceuticals
0.00%
2
CPRX
Catalyst Pharmaceutical Partners
0.00%
2
MYRX
Myrexis
0.00%
Return on Equity
View All
1
AKRX
Akorn
32.28%
2
HITK
Hi - Tech Pharmacal
25.96%
3
SLXP
Salix Pharmaceuticals
20.64%
4
LGND
LIGAND PHARMACEUTICALS
18.82%
5
MYL
Mylan
15.12%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Market Cap
View All| 1 | MYL | Mylan | 8.957B |
|---|---|---|---|
| 2 | WPI | Watson Pharmaceuticals | 8.870B |
| 3 | SLXP | Salix Pharmaceuticals | 3.056B |
| 4 | MRX | Medicis Pharmaceutical Corporati... | 2.070B |
| 5 | PRX | Par Pharmaceutical Companies | 1.272B |
PE Ratio
View All| 1 | HITK | Hi - Tech Pharmacal | 7.234 |
|---|---|---|---|
| 2 | MYL | Mylan | 16.26 |
| 3 | MRX | Medicis Pharmaceutical Corporati... | 21.04 |
| 4 | PRX | Par Pharmaceutical Companies | 22.44 |
| 5 | AKRX | Akorn | 30.93 |
Dividend Yield
View All| 1 | MRX | Medicis Pharmaceutical Corporati... | 1.10% |
|---|---|---|---|
| 2 | TBET | Tibet Pharmaceuticals | 0.00% |
| 2 | SLXP | Salix Pharmaceuticals | 0.00% |
| 2 | CPRX | Catalyst Pharmaceutical Partners | 0.00% |
| 2 | MYRX | Myrexis | 0.00% |
Return on Equity
View All| 1 | AKRX | Akorn | 32.28% |
|---|---|---|---|
| 2 | HITK | Hi - Tech Pharmacal | 25.96% |
| 3 | SLXP | Salix Pharmaceuticals | 20.64% |
| 4 | LGND | LIGAND PHARMACEUTICALS | 18.82% |
| 5 | MYL | Mylan | 15.12% |